TickerFactsScreenerDevelopers

Matinas BioPharma Holdings, Inc. (MTNB) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$3.71M2014: -$10.46M2015: -$9.91M2016: -$8.26M2017: -$16.50M2018: -$14.65M2019: -$18.92M2020: -$24.21M2021: -$24.73M2022: -$24.59M2023: -$23.77M2024: -$24.59M2025: -$6.96M-$6.96M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$6.96M+71.7%
2024-$24.59M-3.5%
2023-$23.77M+3.4%
2022-$24.59M+0.6%
2021-$24.73M-2.2%
2020-$24.21M-27.9%
2019-$18.92M-29.2%
2018-$14.65M+11.2%
2017-$16.50M-99.9%
2016-$8.26M+16.7%
2015-$9.91M+5.3%
2014-$10.46M-181.9%
2013-$3.71M—